| Metallo-intercalators and metallo-insertors BM Zeglis, VC Pierre, JK Barton Chemical Communications, 4565-4579, 2007 | 664 | 2007 |
| PET imaging with 89Zr: from radiochemistry to the clinic MA Deri, BM Zeglis, LC Francesconi, JS Lewis Nuclear medicine and biology 40 (1), 3-14, 2013 | 463 | 2013 |
| Abnormal C5-bound N-heterocyclic carbenes: Extremely strong electron donor ligands and their iridium (I) and iridium (III) complexes AR Chianese, A Kovacevic, BM Zeglis, JW Faller, RH Crabtree Organometallics 23 (10), 2461-2468, 2004 | 396 | 2004 |
| A pretargeted PET imaging strategy based on bioorthogonal Diels–Alder click chemistry BM Zeglis, KK Sevak, T Reiner, P Mohindra, SD Carlin, P Zanzonico, ... Journal of Nuclear Medicine 54 (8), 1389-1396, 2013 | 311 | 2013 |
| Click chemistry and radiochemistry: the first 10 years JP Meyer, P Adumeau, JS Lewis, BM Zeglis Bioconjugate chemistry 27 (12), 2791-2807, 2016 | 240 | 2016 |
| A practical guide to the construction of radiometallated bioconjugates for positron emission tomography BM Zeglis, JS Lewis Dalton Transactions 40 (23), 6168-6195, 2011 | 236 | 2011 |
| Role of Metalation in the Topoisomerase IIα Inhibition and Antiproliferation Activity of a Series of α-Heterocyclic-N4-Substituted Thiosemicarbazones and Their Cu(II … BM Zeglis, V Divilov, JS Lewis Journal of medicinal chemistry 54 (7), 2391-2398, 2011 | 235 | 2011 |
| Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO) MA Deri, S Ponnala, BM Zeglis, G Pohl, JJ Dannenberg, JS Lewis, ... Journal of medicinal chemistry 57 (11), 4849-4860, 2014 | 198 | 2014 |
| Pretargeted imaging and therapy M Altai, R Membreno, B Cook, V Tolmachev, BM Zeglis Journal of Nuclear Medicine 58 (10), 1553-1559, 2017 | 190 | 2017 |
| Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand diels–alder click chemistry BM Zeglis, P Mohindra, GI Weissmann, V Divilov, SA Hilderbrand, ... Bioconjugate chemistry 22 (10), 2048-2059, 2011 | 169 | 2011 |
| Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry BM Zeglis, CB Davis, R Aggeler, HC Kang, A Chen, BJ Agnew, JS Lewis Bioconjugate chemistry 24 (6), 1057-1067, 2013 | 162 | 2013 |
| The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals D Zeng, BM Zeglis, JS Lewis, CJ Anderson Journal of Nuclear Medicine 54 (6), 829-832, 2013 | 153 | 2013 |
| 18F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels–Alder Click Chemistry JP Meyer, JL Houghton, P Kozlowski, D Abdel-Atti, T Reiner, ... Bioconjugate chemistry 27 (2), 298-301, 2016 | 151 | 2016 |
| First-in-human human epidermal growth factor receptor 2–targeted imaging using 89Zr-Pertuzumab PET/CT: dosimetry and clinical application in patients with breast cancer GA Ulaner, SK Lyashchenko, C Riedl, S Ruan, PB Zanzonico, D Lake, ... Journal of Nuclear Medicine 59 (6), 900-906, 2018 | 150* | 2018 |
| Site-specifically labeled immunoconjugates for molecular imaging—part 1: cysteine residues and glycans P Adumeau, SK Sharma, C Brent, BM Zeglis Molecular Imaging and Biology 18, 1-17, 2016 | 120 | 2016 |
| Site-specifically labeled CA19. 9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer JL Houghton, BM Zeglis, D Abdel-Atti, R Aggeler, R Sawada, BJ Agnew, ... Proceedings of the National Academy of Sciences 112 (52), 15850-15855, 2015 | 115 | 2015 |
| Optimization of a pretargeted strategy for the PET imaging of colorectal carcinoma via the modulation of radioligand pharmacokinetics BM Zeglis, C Brand, D Abdel-Atti, KE Carnazza, BE Cook, S Carlin, ... Molecular pharmaceutics 12 (10), 3575-3587, 2015 | 114 | 2015 |
| Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals BM Zeglis, JL Houghton, MJ Evans, N Viola-Villegas, JS Lewis Inorganic chemistry 53 (4), 1880-1899, 2014 | 110 | 2014 |
| The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies BM Zeglis, JS Lewis JoVE (Journal of Visualized Experiments), e52521, 2015 | 106 | 2015 |
| Noninvasive interrogation of DLL3 expression in metastatic small cell lung cancer SK Sharma, J Pourat, D Abdel-Atti, SD Carlin, A Piersigilli, AJ Bankovich, ... Cancer research 77 (14), 3931-3941, 2017 | 103 | 2017 |
Jason S. LewisMSKCC在 mskcc.org 的电子邮件经过验证
